研究論文（110.01～110.12)
| 篇序 |
作者 |
論文題目 | 發表雜誌名稱 (含年月/卷期/頁次) |
屬性 (SCI、SSCI、IEEE) |
|---|---|---|---|---|
| 1 |
許銘仁(1) |
Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort | J Viral Hepat. 2021 Feb;28(2):317-325 | SCIE |
| 2 | 許銘仁(1) | Ocimum gratissimum extract induces apoptosis in gastric cancer cells via modulation of reactive oxygen species and mitogen-activated protein kinase | Current topics in nutraceutical research
Vol 19/NO 04/P 1-6 |
SCI |
| 3 | 許銘仁(1) | In vitro antimicrobial activity of various cefoperazone/sulbactam products | Antibiotics-basel
Vol 09/NO 02/P E77 |
SCI |
| 4 | 許銘仁(1) | Validity of ICD-10-CM codes used to identify patients with chronic hepatitis B and C virus infection in administrative claims data from the Taiwan national health insurance outpatient claims dataset | Clin epidemiol
Vol 12/NO /P 185-192 |
SCI |
| 5 |
許銘仁(1) 林勤益(3) |
Changes in liver-related mortality by etiology and sequelae: Underlying versus Multiple causes of death | Population health metrics
Vol 19/NO 01/P 22- |
SCI |
| 6 |
郭行道(1) |
Eradication of hepatitis C virus preserve liver functionand prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy | Kaohsiung J Med Sci. 2021 Feb;37(2):145-153. | SCI |
| 7 |
郭行道(1) |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV In Taiwan | Scientifc Reports (2021)
11:23473 |
SCI |
| 8 |
郭行道(6) |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan | Liver International. 2021;41:1265–1277. | SCI |
| 9 |
郭行道(4) |
Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution | Viruses 2021, 13, 1316-1328. | SCI |
| 10 |
郭行道(6) |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort) | Journal of Gastroenterology and Hepatology 36 (2021) 2884–2892 | SCI |
| 11 |
郭行道(11) |
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | Viruses 2021, 13, 2294. | SCI |
| 12 |
郭行道(12) |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR) | Clin Gastroenterol Hepatol. 2021 Jul 30;S1542-3565(21)00819-3. | SCI |
| 13 |
郭行道(5) |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis | SCI REP-UK
Vol 10/NO 1/P 5372- |
SCI |
| 14 |
郭行道(5) |
Extrahepatic malignancy among patients with chronic hepatitis C after antiviral therapy: A real-world nationwide study on taiwanese chronic hepatitis C COHORT (T-COACH) | AM J GASTROENTEROL Vol 115/NO /P 1226-1235 | SCI |
| 15 |
郭行道(3) |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis C patients: A nationwide real-world taiwanese COHORT (T-COACH) | OPEN FORUM INFECT DI
Vol 7/NO 10/P 397-406 |
SCI |
| 16 |
馮意哲(C) |
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of the ampulla of Vater: a case report and literature review | Advances in Digestive Medicine (accepted) | |
| 17 |
林育民(1) |
Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy | Cancer Management and Research 2021:13 8037–8047 | SCI |
| 18 |
黃文杰(1) 林育民(2) |
Benefits of Stronger Neo-Minophagen C for acute hepatitis after transarterial chemoembolization therapy for hepatomas | Advances in Digestive Medicine(AIDM) Accepted Date: 04-Aug-2021 | |
| 19 | 王宿鴻(3) | Risk Factors for Early Return Visits to the Emergency Department in Patients Presenting with Nonspecific Abdominal Pain and the Use of Computed Tomography Scan | Healthcare 2021, 9(11), 1470 |
SCIE SSCI |